FDA Panel Gives Thumbs Up to Omicron-Containing COVID Boosters

FDA Panel Gives Thumbs Up to Omicron-Containing COVID Boosters
— Most panelists favored a bivalent vaccine containing a vaccine against the BA.4/BA.5 strains by Joyce Frieden | June 28, 2022 An FDA advisory committee voted 19-2 on Tuesday to recommend use of an Omicron-specific component in a future COVID-19 vaccine booster. “We really do need vaccines that provide broader protection against variants that have not yet emerged,” said Melinda Wharton, MD, MPH, associate director of vaccine policy at the CDC, at a remote meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).… Read the rest

U.S. Expands Monkeypox Vaccination Strategy

U.S. Expands Monkeypox Vaccination Strategy
— Those with presumed exposure now eligible by Kristina Fiore | June 29, 2022 The U.S. is expanding its monkeypox vaccination strategy to include those with a presumed exposure to monkeypox, not just a confirmed exposure, federal officials announced Tuesday evening. The new strategy takes into account the limited doses of the preferred vaccine, Jynneos, according to CDC Director Rochelle Walensky, MD.… Read the rest